THE ROLE OF PHARMACEUTICAL CARE IN THE THERAPEUTIC USE OF KETAMINE
Gabriela Farias, Wanessa Ventura, José Cardoso Filho
Zenodo (CERN European Organization for Nuclear Research) December 8, 2025 preprint DOI: 10.5281/zenodo.17860138 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Bibliographic review |
|---|---|
| Topics | Ketamine Esketamine |
| Keywords | Pharmaceutical care Intensive care medicine Adverse effect Health care Medline Scielo Drug Pharmaceutical industry Medical emergency Anesthetic agent Healthcare regulation |
| Key findings | Pharmaceutical care can assist in monitoring patients undergoing ketamine therapies, particularly regarding safe use, monitoring of adverse effects, guidance on dosage, and adherence to treatment. |
Abstract
The present work aims to analyze the role of pharmaceutical care in the therapeutic use of ketamine, considering its clinical applications, risks, and benefits. This is a bibliographic review research carried out using the PubMed and Scielo databases, as well as books from the health sector library. The analysis focused on the anesthetic ketamine, its indications, side effects, improper recreational use, and how the pharmacist’s role and pharmaceutical care can assist in monitoring patients undergoing ketamine therapies, particularly with regard to safe use, monitoring of adverse effects, guidance on dosage, and adherence to treatment.
Comparable studies
Other narrative reviews on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms | 2018 | Review | |
| Mechanisms of Ketamine Action as an Antidepressant | 2018 | Review | |
| Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation Adults with treatment-resistant depression | 2021 | Review | |
| Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings) | 2013 | Review | |
| A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders | 2017 | Review and consensus statement |